awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33630411-15DBC01B-E64A-4BFA-8464-099C973C2D99
Q33630411-15DBC01B-E64A-4BFA-8464-099C973C2D99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33630411-15DBC01B-E64A-4BFA-8464-099C973C2D99
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists.
P2860
Q33630411-15DBC01B-E64A-4BFA-8464-099C973C2D99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33630411-15DBC01B-E64A-4BFA-8464-099C973C2D99
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6aa760bb77ef186d0e278f2a39319f7c3234d637
P2860
Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.